Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism.

MLA

Chen, Zhike, et al. “Aromatase Deficiency in a Chinese Adult Man Caused by Novel Compound Heterozygous CYP19A1 Mutations: Effects of Estrogen Replacement Therapy on the Bone, Lipid, Liver and Glucose Metabolism.” Molecular and Cellular Endocrinology, vol. 399, Jan. 2015, pp. 32–42. EBSCOhost, https://doi.org/10.1016/j.mce.2014.09.016.

APA

Chen, Z., Wang, O., Nie, M., Elison, K., Zhou, D., Li, M., Jiang, Y., Xia, W., Meng, X., Chen, S., & Xing, X. (2015). Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism. Molecular and Cellular Endocrinology, 399, 32–42. https://doi.org/10.1016/j.mce.2014.09.016

Chicago

Chen, Zhike, Ou Wang, Min Nie, Kathleen Elison, Dujin Zhou, Mei Li, Yan Jiang, et al. 2015. “Aromatase Deficiency in a Chinese Adult Man Caused by Novel Compound Heterozygous CYP19A1 Mutations: Effects of Estrogen Replacement Therapy on the Bone, Lipid, Liver and Glucose Metabolism.” Molecular and Cellular Endocrinology 399 (January): 32–42. doi:10.1016/j.mce.2014.09.016.